Dr. Vincent P. Ferrera's research lab focuses on understanding how the brain learns and processes information, particularly in relation to working memory and inferential reasoning. The lab investigates new methods of using focused ultrasound to improve cognitive functions in models of neurological and psychiatric disorders. This research aims to pave the way for non-addictive treatments that could help those suffering from memory impairments due to conditions like Alzheimer's and schizophrenia.

Dr. Stefano Fusi's lab at Columbia University focuses on understanding how the dentate gyrus, a part of the hippocampus, contributes to cognitive functions like memory and learning, especially in the context of aging and diseases like Alzheimer's. The lab studies adult hippocampal neurogenesis, the process of generating new neurons in the brain, which decreases with aging and is associated with cognitive decline. By exploring this process through genetic and pharmacological approaches, they aim to discover new methods to restore memory function in older individuals.

Dr. Vikram Gadagkar's lab focuses on understanding how the brain of female songbirds processes and evaluates male songs, which can reveal insights into social behaviors and interactions. By studying the neural circuits involved in mate choice, the lab aims to explore the underlying mechanisms of social evaluation, which are relevant to various human social disorders. The research combines approaches from neurobiology, ethology, and computational biology to establish the female songbird as a model for understanding these complex behaviors.

Dr. Suzanne M. Leal's research focuses on understanding the genetic factors behind age-related hearing loss (ARHL) and tinnitus, particularly in diverse populations. She is also investigating the genetic causes of intellectual disability (ID), aiming to identify specific genes involved across various ethnic groups. By leveraging advanced genetic analysis tools and extensive datasets, her lab seeks to improve diagnosis and treatment strategies for these conditions, ultimately aiming to address health disparities.

Dr. Sankar Ghosh's lab focuses on understanding the underlying mechanisms of diseases like Inflammatory Bowel Disease and Alzheimer's Disease. By investigating genetic factors and molecular pathways, the lab aims to identify potential therapeutic targets. Through studies on long noncoding RNAs and mitochondrial function, they seek to reveal how these elements contribute to disease susceptibility and progression.

Dr. Ruben Gonzalez's lab at Columbia University focuses on understanding how the ribosome, a vital cellular structure, translates messenger RNA (mRNA) into proteins. The research explores the structural dynamics and control mechanisms of translation in both bacteria and humans, aiming to uncover new ways to combat diseases linked to translation processes. The lab employs advanced techniques like single-molecule fluorescence and structural biology to study these intricate systems, with the hope of aiding in the development of novel antibiotics and therapeutics.

Dr. Ivaylo Ivanov's lab at Columbia University studies the role of specific immune cells in the gut and how they contribute to obesity and related metabolic diseases. By understanding how certain gut bacteria influence immune responses, the lab aims to uncover new ways to prevent and treat conditions like diabetes and inflammatory bowel disease. The research focuses on the connection between diet, gut immunity, and overall health.

Dr. Harris H. Wang's lab focuses on understanding the complex ecosystems of microorganisms in the gastrointestinal tract, emphasizing how their spatial distribution impacts health and disease. By using advanced techniques like spatial metagenomics and single-cell genomics, the lab investigates how the gut microbiome contributes to digestion, immune responses, and recovery from infections, such as Clostridioides difficile. Their innovative approaches aim to enhance our understanding of microbial roles and pave the way for better microbiome-based therapies.

Dr. Emmanuelle Passegue's lab at Columbia University focuses on understanding how blood cells develop and how their production can go awry in diseases like leukemia and during aging. The research involves investigating how special blood-forming cells adapt to challenges and stressors, which can lead to various blood disorders. By studying these processes, the lab aims to uncover new strategies for improving treatments for blood-related diseases.

Dr. Ulrich Hengst's lab at Columbia University focuses on how neurons respond to stress, particularly through a newly discovered secreted protein that helps protect them during stressful situations. This protein, originating from an important transcription factor, has the potential to improve cell survival and mitochondrial function in receiving neurons. The lab investigates how stress triggers the production of this protective factor, its mechanisms of action, and its broader implications for understanding neuroprotection in the brain.

Dr. Hashim Al-Hashimi's lab at Columbia University focuses on understanding how HIV-1, the virus that causes AIDS, regulates its own replication through RNA structures. By studying the dynamics of RNA and its interactions with proteins, the lab aims to create models that predict how these processes work at a molecular level. This research could lead to new strategies for developing targeted therapies that impede the virus's ability to replicate.

Dr. Krystalyn Hudson's research focuses on understanding autoimmune hemolytic anemia (AIHA), a condition where the immune system mistakenly targets and destroys red blood cells. The lab investigates how the immune system achieves tolerance to red blood cell antigens and what goes wrong in AIHA. They use innovative mouse models to explore the interplay between different T cell populations and signaling molecules involved in immune responses, aiming to develop better strategies for prevention and treatment.

The lab led by Dr. Dalibor Sames at Columbia University focuses on researching iboga alkaloids, particularly ibogaine, which is known for its potential to treat substance use disorders like addiction to opioids and alcohol. The lab is developing safer analogs of ibogaine that maintain therapeutic benefits while minimizing cardiac risks. They also investigate the pharmacological properties of these new compounds in various disease models, aiming to pave the way for innovative treatments for substance addiction and related mental health issues.

Dr. Kristin Kay Baldwin’s research focuses on understanding how inhibitory interneurons, a crucial type of brain cell, develop and function. These neurons play a key role in regulating brain activity and are linked to various neurological disorders like autism and schizophrenia. Her lab aims to discover the genetic programs that allow these neurons to specialize and connect within brain circuits, ultimately leading to new therapies for brain diseases.

Dr. David Roh's lab at Columbia University focuses on improving treatments for patients suffering from intracerebral hemorrhage (ICH), a severe type of stroke. They explore how to better diagnose coagulation issues that lead to ongoing bleeding and worse neurological outcomes in ICH patients. By using advanced blood tests and specialized assays, the lab aims to develop more precise treatments that can prevent complications and improve patient recovery.

Manu Ben Johny's lab at Columbia University focuses on understanding the function and regulation of ion channels in neurons and cardiomyocytes. Their research aims to explore novel mechanisms, such as the role of palmitoylation in calcium channels and the regulation of sodium channels by fibroblast growth factor homologous factor (FHF), to develop new therapeutic strategies for neurological diseases and cardiac arrhythmias.

Dr. Alexander Sobolevsky's lab focuses on understanding the structure and function of important proteins involved in sensory signaling and neurotransmission. His research primarily targets two classes of ion channels: the TRPV3 channel, which is involved in skin sensations and several skin diseases, and ionotropic glutamate receptors (iGluRs), which are crucial for communication in the brain. By exploring how these channels work at a molecular level, the lab aims to lay the groundwork for developing better treatments for various health conditions.

Dr. Iuliana Ionita's lab focuses on understanding the genetic factors that contribute to neuropsychiatric disorders, like autism and schizophrenia. By using comprehensive genetic and phenotypic data, the research aims to develop better methods for analyzing the genetic architecture of these complex traits, particularly in diverse populations. This work seeks to improve our understanding of the biological mechanisms influencing mental health conditions, potentially leading to better prevention and treatment strategies.

Dr. Gerard Karsenty's lab at Columbia University studies the relationship between bone health and aging. The research explores how bones not only decline with age but also play an active role in regulating various bodily functions. By understanding these connections, the lab aims to uncover new ways to combat age-related bone loss and improve overall health during aging.

Dr. Minoree Kohwi's lab at Columbia University investigates how neural progenitors organize their genomes to generate diverse types of neurons during brain development. By studying the Drosophila fruit fly model, the lab explores the relationship between genome organization, gene expression, and neuronal identity, providing insights into fundamental processes of neurodevelopment that are critical for cognitive and motor functions.